SIGA Technologies Inc (SIGA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
SIGA Technologies Inc stock (SIGA) is currently trading at $5.00. SIGA Technologies Inc PE ratio is 15.59. SIGA Technologies Inc PS ratio (Price-to-Sales) is 3.78. Analyst consensus price target for SIGA is $17.53. WallStSmart rates SIGA as Underperform.
- SIGA PE ratio analysis and historical PE chart
- SIGA PS ratio (Price-to-Sales) history and trend
- SIGA intrinsic value — DCF, Graham Number, EPV models
- SIGA stock price prediction 2025 2026 2027 2028 2029 2030
- SIGA fair value vs current price
- SIGA insider transactions and insider buying
- Is SIGA undervalued or overvalued?
- SIGA Technologies Inc financial analysis — revenue, earnings, cash flow
- SIGA Piotroski F-Score and Altman Z-Score
- SIGA analyst price target and Smart Rating
SIGA Technologies Inc
📊 No data available
Try selecting a different time range
SIGA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · SIGA Technologies Inc (SIGA)
SIGA trades at a significant discount to its Graham intrinsic value of $14.98, offering a 56% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
SIGA Technologies Inc (SIGA) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, eps growth, profit margin. Concerns around peg ratio and operating margin. Fundamentals are solid but monitor weak areas for improvement.
SIGA Technologies Inc (SIGA) Key Strengths (4)
Earnings per share surging 1802.00% year-over-year
Keeps $25 of every $100 in revenue as net profit
Trading at 1.78x book value, attractively priced
52.00% held by institutions, strong professional interest
Supporting Valuation Data
SIGA Technologies Inc (SIGA) Areas to Watch (6)
Losing money on operations
Revenue declining -95.30%, a shrinking business
Very expensive relative to growth, significant premium
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Revenue is fairly priced at 3.78x sales
Supporting Valuation Data
SIGA Technologies Inc (SIGA) Detailed Analysis Report
Overall Assessment
This company scores 54/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Profit Margin, Price/Book. Valuation metrics including Price/Book (1.78) suggest the stock is attractively priced. Profitability is solid with Profit Margin at 24.60%. Growth metrics are encouraging with EPS Growth at 1802.00%.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, PEG Ratio. Some valuation metrics including PEG Ratio (3.37), Price/Sales (3.78) suggest expensive pricing. Growth concerns include Revenue Growth at -95.30%, which may limit upside. Profitability pressure is visible in Return on Equity at 11.20%, Operating Margin at -250.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 11.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -95.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Profit Margin) and negatives (Operating Margin, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SIGA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SIGA's Price-to-Sales ratio of 3.78x trades at a deep discount to its historical average of 28.7x (4th percentile). The current valuation is 95% below its historical high of 80.79x set in Nov 2009, and 226% above its historical low of 1.16x in Jan 2019. Over the past 12 months, the PS ratio has expanded from ~2.7x, reflecting growing market expectations outpacing revenue growth.
Compare SIGA with Competitors
Top DRUG MANUFACTURERS - SPECIALTY & GENERIC stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for SIGA Technologies Inc (SIGA) · HEALTHCARE › DRUG MANUFACTURERS - SPECIALTY & GENERIC
The Big Picture
SIGA Technologies Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 95M with 95% decline year-over-year. Profit margins are strong at 24.6%, reflecting pricing power and operational efficiency.
Key Findings
Debt-to-equity ratio of 0.00 indicates a conservative balance sheet with 172M in cash.
Revenue contracted 95% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -17M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive moves, and regulatory changes that could impact SIGA Technologies Inc.
Bottom Line
SIGA Technologies Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(19 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 10:09:50 AM
About SIGA Technologies Inc(SIGA)
NASDAQ
HEALTHCARE
DRUG MANUFACTURERS - SPECIALTY...
USA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered in New York, New York.